ELAN News and Press, Elanco Animal Health Incorporated From 04/27/22

Elanco Animal Health (NYSE:ELAN) has obtained the exclusive U.S. licensing rights to Bovaer, methane-reducing feed additive approved in Europe, Brazil, Chile and Australia for beef and dairy cattle. The transaction announced on Monday follows a strategic alliance with Royal DSM, under which t...

The strategic alliance connects two sustainability leaders, Elanco, a leading animal health company, and Royal DSM, a health, nutrition and biosciences company, to accelerate tangible sustainable solutions in the U.S., supporting the Global Methane Pledge goal of cutting emissions 30%...

Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...

Elanco Animal Health is coming off a record 2021 highlighted by strong earnings. The stock has been under pressure amid macro concerns including an ongoing Bird Flu outbreak with an uncertain impact on the company's poultry business. We like the stock following on the selloff with...

Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...

Elanco Animal Health Incorporated (NYSE: ELAN) will announce its first quarter 2022 financial results on Monday, May 9, 2022. Elanco will also conduct a conference call on that day with the investment community and media to further detail the company’s performance. The confer...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Cell programming company Ginkgo Bioworks  (NYSE: DNA ) is in the green today on promising new collaboration announcements. DNA stock is up more than 10% heading into market close as investors seem pleased by the n...

More than a building, new headquarters represents Elanco’s endeavor to build a post-COVID workplace destination, the company’s next era of growth an innovation, an expanded downtown Indianapolis that connects the Valley Neighborhood with the Circle, and an epicenter for ...

Elanco Animal Health Incorporated (NYSE: ELAN) (“Elanco”) today announced that as of 5:00 p.m., New York City time, on April 11, 2022 (the “Early Tender Time”), holders of approximately $406,391,000 aggregate principal amount, or approximately 54.19% of the o...

Elanco and Ginkgo Bioworks Launch BiomEdit, a New Animal Health Company Leveraging Microbiome Technology PR Newswire BiomEdit intends to discover and develop animal health products that leverage microbiome science to improve animal health, animal protein production, an...